The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Preimplantation Genetic Testing-Global Market Insights and Sales Trends 2024
Synopsis
Preimplantation genetic testing is a technique used to identify genetic defects in embryos created through in vitro fertilization (IVF) before pregnancy. Preimplantation genetic diagnosis (PGD) refers specifically to when one or both genetic parents has a known genetic abnormality and testing is performed on an embryo to determine if it also carries a genetic abnormality. In contrast, preimplantation genetic screening (PGS) refers to techniques where embryos from presumed chromosomally normal genetic parents are screened for aneuploidy.
The global Preimplantation Genetic Testing market size is expected to reach US$ 528.9 million by 2029, growing at a CAGR of 5.8% from 2023 to 2029. The market is mainly driven by the significant applications of Preimplantation Genetic Testing in various end use industries. The expanding demands from the Maternity Centers & Fertility Clinics, Hospitals, Diagnostic Labs, and Service Providers and Research Laboratories & Academic Institutes,, are propelling Preimplantation Genetic Testing market. Preimplantation Genetic Screening, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Preimplantation Genetic Diagnosis segment is estimated at % CAGR for the next seven-year period.
North America accounted for the largest share of the global preimplantation genetic testing market in 2017, followed by Europe. The large share in the North American region is mainly attributed to the rising number of IVF procedures (with decreasing fertility rates), significant adoption of genomic techniques, and the ongoing trend of replacing traditional genomic technologies with advanced and innovative genetic techniques (such as FISH and NGS). The Asia-Pacific region is expected to register the highest growth rate during the forecast period, due to the growing focus of players on emerging markets and improvements in healthcare infrastructure in these regions.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Preimplantation Genetic Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Preimplantation Genetic Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Preimplantation Genetic Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Preimplantation Genetic Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Preimplantation Genetic Testing covered in this report include Illumina, Thermo Fisher, Agilent Technologies, Perkinelmer, Coopersurgical, Abbott Laboratories, Natera, Rubicon Genomics and Oxford Gene Technology, etc.
The global Preimplantation Genetic Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Illumina
Thermo Fisher
Agilent Technologies
Perkinelmer
Coopersurgical
Abbott Laboratories
Natera
Rubicon Genomics
Oxford Gene Technology
Yikon Genomics
Scigene
Beijing Genomics Institute
Good Start Genetics
Invicta Genetics
Combimatrix
Genea Limited
Progenesis
Global Preimplantation Genetic Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Preimplantation Genetic Testing market, Segment by Type:
Preimplantation Genetic Screening
Preimplantation Genetic Diagnosis
Global Preimplantation Genetic Testing market, by Application
Maternity Centers & Fertility Clinics
Hospitals, Diagnostic Labs, and Service Providers
Research Laboratories & Academic Institutes
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Preimplantation Genetic Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Preimplantation genetic testing is a technique used to identify genetic defects in embryos created through in vitro fertilization (IVF) before pregnancy. Preimplantation genetic diagnosis (PGD) refers specifically to when one or both genetic parents has a known genetic abnormality and testing is performed on an embryo to determine if it also carries a genetic abnormality. In contrast, preimplantation genetic screening (PGS) refers to techniques where embryos from presumed chromosomally normal genetic parents are screened for aneuploidy.
The global Preimplantation Genetic Testing market size is expected to reach US$ 528.9 million by 2029, growing at a CAGR of 5.8% from 2023 to 2029. The market is mainly driven by the significant applications of Preimplantation Genetic Testing in various end use industries. The expanding demands from the Maternity Centers & Fertility Clinics, Hospitals, Diagnostic Labs, and Service Providers and Research Laboratories & Academic Institutes,, are propelling Preimplantation Genetic Testing market. Preimplantation Genetic Screening, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Preimplantation Genetic Diagnosis segment is estimated at % CAGR for the next seven-year period.
North America accounted for the largest share of the global preimplantation genetic testing market in 2017, followed by Europe. The large share in the North American region is mainly attributed to the rising number of IVF procedures (with decreasing fertility rates), significant adoption of genomic techniques, and the ongoing trend of replacing traditional genomic technologies with advanced and innovative genetic techniques (such as FISH and NGS). The Asia-Pacific region is expected to register the highest growth rate during the forecast period, due to the growing focus of players on emerging markets and improvements in healthcare infrastructure in these regions.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Preimplantation Genetic Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Preimplantation Genetic Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Preimplantation Genetic Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Preimplantation Genetic Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Preimplantation Genetic Testing covered in this report include Illumina, Thermo Fisher, Agilent Technologies, Perkinelmer, Coopersurgical, Abbott Laboratories, Natera, Rubicon Genomics and Oxford Gene Technology, etc.
The global Preimplantation Genetic Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Illumina
Thermo Fisher
Agilent Technologies
Perkinelmer
Coopersurgical
Abbott Laboratories
Natera
Rubicon Genomics
Oxford Gene Technology
Yikon Genomics
Scigene
Beijing Genomics Institute
Good Start Genetics
Invicta Genetics
Combimatrix
Genea Limited
Progenesis
Global Preimplantation Genetic Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Preimplantation Genetic Testing market, Segment by Type:
Preimplantation Genetic Screening
Preimplantation Genetic Diagnosis
Global Preimplantation Genetic Testing market, by Application
Maternity Centers & Fertility Clinics
Hospitals, Diagnostic Labs, and Service Providers
Research Laboratories & Academic Institutes
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Preimplantation Genetic Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Preimplantation Genetic Testing
1.1 Preimplantation Genetic Testing Market Overview
1.1.1 Preimplantation Genetic Testing Product Scope
1.1.2 Preimplantation Genetic Testing Market Status and Outlook
1.2 Global Preimplantation Genetic Testing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Preimplantation Genetic Testing Market Size by Region (2018-2029)
1.4 Global Preimplantation Genetic Testing Historic Market Size by Region (2018-2023)
1.5 Global Preimplantation Genetic Testing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Preimplantation Genetic Testing Market Size (2018-2029)
1.6.1 North America Preimplantation Genetic Testing Market Size (2018-2029)
1.6.2 Europe Preimplantation Genetic Testing Market Size (2018-2029)
1.6.3 Asia-Pacific Preimplantation Genetic Testing Market Size (2018-2029)
1.6.4 Latin America Preimplantation Genetic Testing Market Size (2018-2029)
1.6.5 Middle East & Africa Preimplantation Genetic Testing Market Size (2018-2029)
2 Preimplantation Genetic Testing Market by Type
2.1 Introduction
2.1.1 Preimplantation Genetic Screening
2.1.2 Preimplantation Genetic Diagnosis
2.2 Global Preimplantation Genetic Testing Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Preimplantation Genetic Testing Historic Market Size by Type (2018-2023)
2.2.2 Global Preimplantation Genetic Testing Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Preimplantation Genetic Testing Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Preimplantation Genetic Testing Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Preimplantation Genetic Testing Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Preimplantation Genetic Testing Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Preimplantation Genetic Testing Revenue Breakdown by Type (2018-2029)
3 Preimplantation Genetic Testing Market Overview by Application
3.1 Introduction
3.1.1 Maternity Centers & Fertility Clinics
3.1.2 Hospitals, Diagnostic Labs, and Service Providers
3.1.3 Research Laboratories & Academic Institutes
3.2 Global Preimplantation Genetic Testing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Preimplantation Genetic Testing Historic Market Size by Application (2018-2023)
3.2.2 Global Preimplantation Genetic Testing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Preimplantation Genetic Testing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Preimplantation Genetic Testing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Preimplantation Genetic Testing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Preimplantation Genetic Testing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Preimplantation Genetic Testing Revenue Breakdown by Application (2018-2029)
4 Preimplantation Genetic Testing Competition Analysis by Players
4.1 Global Preimplantation Genetic Testing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Preimplantation Genetic Testing as of 2022)
4.3 Date of Key Players Enter into Preimplantation Genetic Testing Market
4.4 Global Top Players Preimplantation Genetic Testing Headquarters and Area Served
4.5 Key Players Preimplantation Genetic Testing Product Solution and Service
4.6 Competitive Status
4.6.1 Preimplantation Genetic Testing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Illumina
5.1.1 Illumina Profile
5.1.2 Illumina Main Business
5.1.3 Illumina Preimplantation Genetic Testing Products, Services and Solutions
5.1.4 Illumina Preimplantation Genetic Testing Revenue (US$ Million) & (2018-2023)
5.1.5 Illumina Recent Developments
5.2 Thermo Fisher
5.2.1 Thermo Fisher Profile
5.2.2 Thermo Fisher Main Business
5.2.3 Thermo Fisher Preimplantation Genetic Testing Products, Services and Solutions
5.2.4 Thermo Fisher Preimplantation Genetic Testing Revenue (US$ Million) & (2018-2023)
5.2.5 Thermo Fisher Recent Developments
5.3 Agilent Technologies
5.3.1 Agilent Technologies Profile
5.3.2 Agilent Technologies Main Business
5.3.3 Agilent Technologies Preimplantation Genetic Testing Products, Services and Solutions
5.3.4 Agilent Technologies Preimplantation Genetic Testing Revenue (US$ Million) & (2018-2023)
5.3.5 Perkinelmer Recent Developments
5.4 Perkinelmer
5.4.1 Perkinelmer Profile
5.4.2 Perkinelmer Main Business
5.4.3 Perkinelmer Preimplantation Genetic Testing Products, Services and Solutions
5.4.4 Perkinelmer Preimplantation Genetic Testing Revenue (US$ Million) & (2018-2023)
5.4.5 Perkinelmer Recent Developments
5.5 Coopersurgical
5.5.1 Coopersurgical Profile
5.5.2 Coopersurgical Main Business
5.5.3 Coopersurgical Preimplantation Genetic Testing Products, Services and Solutions
5.5.4 Coopersurgical Preimplantation Genetic Testing Revenue (US$ Million) & (2018-2023)
5.5.5 Coopersurgical Recent Developments
5.6 Abbott Laboratories
5.6.1 Abbott Laboratories Profile
5.6.2 Abbott Laboratories Main Business
5.6.3 Abbott Laboratories Preimplantation Genetic Testing Products, Services and Solutions
5.6.4 Abbott Laboratories Preimplantation Genetic Testing Revenue (US$ Million) & (2018-2023)
5.6.5 Abbott Laboratories Recent Developments
5.7 Natera
5.7.1 Natera Profile
5.7.2 Natera Main Business
5.7.3 Natera Preimplantation Genetic Testing Products, Services and Solutions
5.7.4 Natera Preimplantation Genetic Testing Revenue (US$ Million) & (2018-2023)
5.7.5 Natera Recent Developments
5.8 Rubicon Genomics
5.8.1 Rubicon Genomics Profile
5.8.2 Rubicon Genomics Main Business
5.8.3 Rubicon Genomics Preimplantation Genetic Testing Products, Services and Solutions
5.8.4 Rubicon Genomics Preimplantation Genetic Testing Revenue (US$ Million) & (2018-2023)
5.8.5 Rubicon Genomics Recent Developments
5.9 Oxford Gene Technology
5.9.1 Oxford Gene Technology Profile
5.9.2 Oxford Gene Technology Main Business
5.9.3 Oxford Gene Technology Preimplantation Genetic Testing Products, Services and Solutions
5.9.4 Oxford Gene Technology Preimplantation Genetic Testing Revenue (US$ Million) & (2018-2023)
5.9.5 Oxford Gene Technology Recent Developments
5.10 Yikon Genomics
5.10.1 Yikon Genomics Profile
5.10.2 Yikon Genomics Main Business
5.10.3 Yikon Genomics Preimplantation Genetic Testing Products, Services and Solutions
5.10.4 Yikon Genomics Preimplantation Genetic Testing Revenue (US$ Million) & (2018-2023)
5.10.5 Yikon Genomics Recent Developments
5.11 Scigene
5.11.1 Scigene Profile
5.11.2 Scigene Main Business
5.11.3 Scigene Preimplantation Genetic Testing Products, Services and Solutions
5.11.4 Scigene Preimplantation Genetic Testing Revenue (US$ Million) & (2018-2023)
5.11.5 Scigene Recent Developments
5.12 Beijing Genomics Institute
5.12.1 Beijing Genomics Institute Profile
5.12.2 Beijing Genomics Institute Main Business
5.12.3 Beijing Genomics Institute Preimplantation Genetic Testing Products, Services and Solutions
5.12.4 Beijing Genomics Institute Preimplantation Genetic Testing Revenue (US$ Million) & (2018-2023)
5.12.5 Beijing Genomics Institute Recent Developments
5.13 Good Start Genetics
5.13.1 Good Start Genetics Profile
5.13.2 Good Start Genetics Main Business
5.13.3 Good Start Genetics Preimplantation Genetic Testing Products, Services and Solutions
5.13.4 Good Start Genetics Preimplantation Genetic Testing Revenue (US$ Million) & (2018-2023)
5.13.5 Good Start Genetics Recent Developments
5.14 Invicta Genetics
5.14.1 Invicta Genetics Profile
5.14.2 Invicta Genetics Main Business
5.14.3 Invicta Genetics Preimplantation Genetic Testing Products, Services and Solutions
5.14.4 Invicta Genetics Preimplantation Genetic Testing Revenue (US$ Million) & (2018-2023)
5.14.5 Invicta Genetics Recent Developments
5.15 Combimatrix
5.15.1 Combimatrix Profile
5.15.2 Combimatrix Main Business
5.15.3 Combimatrix Preimplantation Genetic Testing Products, Services and Solutions
5.15.4 Combimatrix Preimplantation Genetic Testing Revenue (US$ Million) & (2018-2023)
5.15.5 Combimatrix Recent Developments
5.16 Genea Limited
5.16.1 Genea Limited Profile
5.16.2 Genea Limited Main Business
5.16.3 Genea Limited Preimplantation Genetic Testing Products, Services and Solutions
5.16.4 Genea Limited Preimplantation Genetic Testing Revenue (US$ Million) & (2018-2023)
5.16.5 Genea Limited Recent Developments
5.17 Progenesis
5.17.1 Progenesis Profile
5.17.2 Progenesis Main Business
5.17.3 Progenesis Preimplantation Genetic Testing Products, Services and Solutions
5.17.4 Progenesis Preimplantation Genetic Testing Revenue (US$ Million) & (2018-2023)
5.17.5 Progenesis Recent Developments
6 North America
6.1 North America Preimplantation Genetic Testing Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Preimplantation Genetic Testing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Preimplantation Genetic Testing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Preimplantation Genetic Testing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Preimplantation Genetic Testing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Preimplantation Genetic Testing Market Dynamics
11.1 Preimplantation Genetic Testing Industry Trends
11.2 Preimplantation Genetic Testing Market Drivers
11.3 Preimplantation Genetic Testing Market Challenges
11.4 Preimplantation Genetic Testing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
